21st Gene Forum 2022
Tartu, Estonia
September 2-3, 2022 (Hybrid meeting)
The Institute of Genomics of the University of Tartu and Gene Center cordially invites you to The 21st International Gene Forum 2022 on September 2-3, 2022
After two years not being able to organize a traditional conference, we are glad to announce that this year we organizing a hybrid meeting at the Estonian National Museum.
An annual international high-level scientific conference on genetics and genomics, the major event in Baltics, provides an excellent opportunity to establish and renew contacts in the region.
Due to its interdisciplinary scope, Gene Forum 2022 brings together 21 distinguished experts from Europe and US for discussion of the progress in the field. Speakers will discuss wide range of topics like personalized medicine in psychiatry, microbiome and population genomics, Parkinson disease and epigenetics.
As the organizers, we hope that the forthcoming Gene Forum 2022 will create an inspiring environment to exchange ideas and experiences. The conference will take place in Tartu, the second biggest City of Estonia, rich in academic and historical traditions. We hope that your stay in Tartu will be both enjoyable and professionally stimulating.
End of registration to the conference will be on August 25, 2022.
Register now
Programme
| DAY 1 Friday, September 2nd, 2022 |
||||
|---|---|---|---|---|
| Time (EET) in hrs | Theme | Moderator | Speaker | Talk title |
| 09:00 – 09:30 | REGISTRATION | |||
| 09:15 – 09:30 | OPENING OF THE CONFERENCE | Welcome by Toomas Asser, Rector, University of Tartu, Estonia | ||
| 09:30 – 11:30 | Personalized medicine in psychiatry | Lili Milani and Kelli Lehto | Professor Brenda Penninx Amsterdam UMC Netherlands |
Using genetics to unravel the heterogeneity of depression |
| Professor Henrik Larsson Karolinska Institute Sweden |
Psychiatric epidemiology using national register data: Challenges and opportunities | |||
| Dr. Christiane Gasse Ahrus University Denmark |
From associations to clinical utility: impact of functional CYP2C19 and CYP2D6 gene variants on treatment in patients with depression: a Danish cohort study | |||
| Dr. Lu Yi Karolinska Institute Sweden |
A multidisciplinary approach to better understand treatment resistant depression | |||
| 11:30 – 12:30 | LUNCH BREAK | |||
| 12:30 – 14:00 | A tour at the Estonian National Museum | |||
| 14:00 – 16:00 | Immunology and Epigenetics | Pärt Peterson and Ana Rebane | Professor Dario Greco University of Tampere Finland |
Integrated approaches to chemical safety assessment and drug design |
| Dr. Ulf Andersson Vang Orom Aarhus University Denmark |
m6A RNA modifications, splicing and cancer | |||
| Dr. Benjamin Fairfax University of Oxford United Kingdom |
Exploring the interplay between germline genetic variation and responses to cancer immunotherapy and chronic viral infection across a large patient cohort | |||
| Anne Puel French Institute of Health and Medical Research France |
Autoimmune phenocopies of inborn errors of immunity underlying infectious diseases | |||
| 16:00 – 16:30 | COFFEE BREAK | |||
| 16:30 – 18:30 | Genetic and phenotypic variance | Kaur Alasoo | Dr. Claudia Langenberg University of Cambridge/ Berlin Institute of Health at Charité United Kingdom/Germany |
From molecules to health records: utility of omics at population scale |
| Dietmar Frey CLAIM – the Charité Lab for AI in Medicine Germany |
Diversity in genomic studies: the transferability of complex trait loci and its impact on downstream applications | |||
| Elo Madisson Wellcome Sanger Institute United Kingdom |
A spatial multi-omics atlas of the human lung reveals a novel gland-associated immune niche | |||
| Ewan Birney EMBL-EBI United Kingdom |
Big data in biology: what the pandemic has taught us | |||
| 19:00 – 00:00 | DINNER at Estonian National Museum | |||
| DAY 2 Saturday, September 3rd, 2022 |
||||
|---|---|---|---|---|
| Time (EET) in hrs | Theme | Moderator | Speaker | Talk title |
| 09:30 – 12:00 | – | – | Michael Simpson Kings College London United Kingdom |
Driving discovery in inflammatory skin disease with human genetics |
| Lisa Bastarache Vanderbilt University Medical Center United States of America |
Studying rare variants at the population level: How EHR-linked biobanks give us new insight into monogenic disease | |||
| – | Presentation by Illumina | Tiffany Morris
Kalina Cetnar |
Illumina toolkit for PGx and PRS | |
| 12:00 – 13:30 | LUNCH BREAK | |||
| 13:30 – 15:00 | Parkinson Disease | Andres Metspalu | Professor Mart Saarma University of Helsinki Finland |
Search for new molecules to cure Parkinson’s disease |
| Dr. Alastair Noyce London’s Global University United Kingdom |
Determinants of Parkinson’s disease – genes, environment and interactions | |||
| Dr. Toomas Toomsoo Confido Medical Center Estonia |
Polygenic risk score for Parkinson’s disease and probability of substantia nigra hyperechogenicity in “healthy” adults | |||
| 15:00 – 15:30 | COFFEE BREAK | |||
| 15:30 – 17:10 | Microbiome and population genomics | Mait Metspalu and Elin Org | Paul Wilmes University of Luxembourg Luxembourg |
Systems Ecology of Human-Microbiome Interactions in Health and Disease |
| Leo Lahti Univerity of Turku Finland |
Emerging computational approaches in population studies of the human microbiome | |||
| Adrian Tett University of Vienna Austria |
The impact of Westernization on the human gut microbiome | |||
| Hannes Schroeder University of Copenhagen Denmark |
Challenges and prospects in ancient metagenomcis | |||
| 17:10 – 17:15 | CLOSING REMARKS | |||
